Simcyp™ PBPK Simulator
Streamlines drug development by using PBPK modeling to predict drug behavior in virtual populations, optimize…
Jim Gallagher2021年1月22日
How PBPK Modeling Can Replace Drug-Drug Interaction Studies
Patients often take more than one drug at a time, especially elderly patients and those…
Certara2020年11月12日
Galderma Achieves FDA Approval of AKLIEF® (trifarotene)
In October 2019, Galderma announced that the U.S. FDA approved AKLIEF® (trifarotene) Cream, 0.005% for the…
Certara2020年11月9日
PBPK modeling supports approval of breakthrough cancer drug
Pharmacyclics’ (now AbbVie) Imbruvica (ibrutinib) is an anticancer drug targeting B-cell malignancies. Leveraging the US…
Certara2020年10月23日
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy
Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in…
Jieun Choe2020年10月12日
